These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 33595954)

  • 1. Tetracyclines, a promise for neuropsychiatric disorders: from adjunctive therapy to the discovery of new targets for rational drug design in psychiatry.
    Chaves Filho AJM; Mottin M; Soares MV; Jucá PM; Andrade CH; Macedo DS
    Behav Pharmacol; 2021 Apr; 32(2&3):123-141. PubMed ID: 33595954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repurposing of Tetracyclines for COVID-19 Neurological and Neuropsychiatric Manifestations: A Valid Option to Control SARS-CoV-2-Associated Neuroinflammation?
    Chaves Filho AJM; Gonçalves F; Mottin M; Andrade CH; Fonseca SNS; Macedo DS
    J Neuroimmune Pharmacol; 2021 Jun; 16(2):213-218. PubMed ID: 33534108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-activated microglial mediators of neuronal survival are differentially regulated by tetracyclines.
    Lai AY; Todd KG
    Glia; 2006 Jun; 53(8):809-16. PubMed ID: 16541436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetracycline repurposing in neurodegeneration: focus on Parkinson's disease.
    Bortolanza M; Nascimento GC; Socias SB; Ploper D; Chehín RN; Raisman-Vozari R; Del-Bel E
    J Neural Transm (Vienna); 2018 Oct; 125(10):1403-1415. PubMed ID: 30109452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minocycline: therapeutic potential in psychiatry.
    Dean OM; Data-Franco J; Giorlando F; Berk M
    CNS Drugs; 2012 May; 26(5):391-401. PubMed ID: 22486246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of inhibitory actions of minocycline and doxycycline on ascitic fluid production induced by mouse fibrosarcoma cells.
    Wakai K; Ohmura E; Satoh T; Murakami H; Isozaki O; Emoto N; Demura H; Shizume K; Tsushima T
    Life Sci; 1994; 54(11):703-9. PubMed ID: 8107519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetracyclines: drugs with huge therapeutic potential.
    Bahrami F; Morris DL; Pourgholami MH
    Mini Rev Med Chem; 2012 Jan; 12(1):44-52. PubMed ID: 22070692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxycycline reverses cognitive impairment, neuroinflammation and oxidative imbalance induced by D-amphetamine mania model in mice: A promising drug repurposing for bipolar disorder treatment?
    Chaves Filho AJM; Cunha NL; Rodrigues PA; de Souza AG; Soares MV; Jucá PM; de Queiroz T; Clemente DCDS; Mottin M; Andrade CH; Peixoto CA; Macedo DS
    Eur Neuropsychopharmacol; 2021 Jan; 42():57-74. PubMed ID: 33191076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory tetracyclines shape the intestinal inflammatory response inducing mucosal healing and resolution.
    Garrido-Mesa J; Rodríguez-Nogales A; Algieri F; Vezza T; Hidalgo-Garcia L; Garrido-Barros M; Utrilla MP; Garcia F; Chueca N; Rodriguez-Cabezas ME; Garrido-Mesa N; Gálvez J
    Br J Pharmacol; 2018 Dec; 175(23):4353-4370. PubMed ID: 30184260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia.
    Yrjänheikki J; Keinänen R; Pellikka M; Hökfelt T; Koistinaho J
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15769-74. PubMed ID: 9861045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature.
    Griffin MO; Fricovsky E; Ceballos G; Villarreal F
    Am J Physiol Cell Physiol; 2010 Sep; 299(3):C539-48. PubMed ID: 20592239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-response effect of tetracyclines on cerebral matrix metalloproteinase-9 after vascular endothelial growth factor hyperstimulation.
    Lee CZ; Yao JS; Huang Y; Zhai W; Liu W; Guglielmo BJ; Lin E; Yang GY; Young WL
    J Cereb Blood Flow Metab; 2006 Sep; 26(9):1157-64. PubMed ID: 16395286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-antibacterial tetracyclines modulate mediators of periodontitis and atherosclerotic cardiovascular disease: a mechanistic link between local and systemic inflammation.
    Gu Y; Lee HM; Sorsa T; Salminen A; Ryan ME; Slepian MJ; Golub LM
    Pharmacol Res; 2011 Dec; 64(6):573-9. PubMed ID: 21771657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.
    Cerbo AD
    Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetracyclines: nonantibiotic properties and their clinical implications.
    Sapadin AN; Fleischmajer R
    J Am Acad Dermatol; 2006 Feb; 54(2):258-65. PubMed ID: 16443056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mechanism of action of tetracyclines: effects on nitric oxide synthases.
    Amin AR; Attur MG; Thakker GD; Patel PD; Vyas PR; Patel RN; Patel IR; Abramson SB
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14014-9. PubMed ID: 8943052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetracycline antibiotics and resistance mechanisms.
    Nguyen F; Starosta AL; Arenz S; Sohmen D; Dönhöfer A; Wilson DN
    Biol Chem; 2014 May; 395(5):559-75. PubMed ID: 24497223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Putative neuroprotective pharmacotherapies to target the staged progression of mental illness.
    Robertson OD; Coronado NG; Sethi R; Berk M; Dodd S
    Early Interv Psychiatry; 2019 Oct; 13(5):1032-1049. PubMed ID: 30690898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetracyclines and chemically modified tetracycline-3 (CMT-3) modulate cytokine secretion by lipopolysaccharide-stimulated whole blood.
    Cazalis J; Tanabe S; Gagnon G; Sorsa T; Grenier D
    Inflammation; 2009 Apr; 32(2):130-7. PubMed ID: 19238528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effects of tetracyclines: molecular targets, animal models and human disease.
    Orsucci D; Calsolaro V; Mancuso M; Siciliano G
    CNS Neurol Disord Drug Targets; 2009 Jun; 8(3):222-31. PubMed ID: 19601819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.